Samsung Bioepis, Celltrion, GenScript and more—FiercePharmaAsia by Angus Liu Friday, July 26, 2019 Samsung Bioepis wins FDA nod for a Humira biosim; Celltrion forms Chinese biosim joint venture; GenScript debuts a clinical biologics plant.
Chinese CDMO GenScript opens first biologics production facility by Eric Palmer Tuesday, July 23, 2019 Chinese CDMO GenScript Biotech opened a new biologics clinical supply manufacturing facility even as it is working on a commercial supply facility.
U.S. generics players, Chi-Med and more—FiercePharmaAsia by Angus Liu Friday, April 19, 2019 Indian drugmakers pick up U.S. generics scripts; Chi-Med files for Hong Kong listing; an explosion at a Qilu Pharma subsidiary kills 10.
China's GenScript starts on plasmid, virus making facility by Eric Palmer Tuesday, April 16, 2019 Chinese CDMO GenScript Biotech has started construction on a production facility to specialize in plasmids and viruses manufacturing.
Nobel Prize, Legend Biotech and more—FiercePharmaAsia by Angus Liu Friday, October 5, 2018 Tasuku Honjo wins Nobel Prize for PD-1 research; Legend fires back at CAR-T data fabrication allegation; Takeda alumni demand more on Shire buyout.
FiercePharmaAsia—Nanjing Legend, Eisai-Biogen, Impax and more by Angus Liu Friday, January 5, 2018 Legend teams with J&J on CAR-T project, Eisai and Biogen's Alzheimer's drug fails in early readout, Impax and Bora Pharma ink deal.
